Goodwin advised Eurazeo as mandated lead arranger on new refinancing and add-on acquisition facilities for United Therapy Group ("United Therapy"). United Therapy is a portfolio company of funds advised by Quadriga Capital Eigenkapitalberatung GmbH.
Eurazeo is a leading global investment group with €36.8bn in diversified assets under management, including €27.5bn on behalf of institutional and private clients through its private equity, private debt, real estate and infrastructure strategies. The Group supports around 600 companies, leveraging the commitment of over 400 employees, its sector expertise, its privileged access to global markets via the group's 13 offices in Europe, Asia and the United States, and its responsible approach to value creation based on growth.
United Therapy is the leading holistic platform helping people overcome back, muscle, joint and related conditions across Germany. The Group has built an innovative ecosystem for integrated care solutions in physiotherapy, occupational therapy and speech therapy along the whole treatment chain. This includes outpatient, home treatment, blended care programs and digital offerings. United Therapy currently employs over 850 people in more than 70 NOVOTERGUM centres in Germany and is growing dynamically both by expanding its services portfolio and partnering with like-minded therapy providers.
Quadriga Capital Eigenkapitalberatung GmbH is an independent investment adviser focused on shaping differentiated medium-sized growth companies and building integrated platforms in the German-speaking markets. Since its launch more than 30 years ago, Quadriga Capital has successfully arranged and advised on over 220 transactions across its core sectors Essential Healthcare, Tech-enabled Services and Smart Industries.
Goodwin's transaction team was led by partner Folko Moroni and included associates Rebecca Stöcklein, Philipp Lehle (all Private Equity/Finance) and Philipp Lauer (Tax).